08 Apr

German Healthcare Alliance

The German Healthcare Alliance (GHA) has invited BioPortUSA to speak at their inaugural event on April 16, 2024. Mark Lesselroth will address the audience on what it takes to be successful in the U.S. healthcare market. The GHA consists of more than 100 leading German actors virtually from all sectors: private sector and industry, NGOs, civil society and foundations, science and academia.

This first event is meant to serve as an icebreaker for their members to gain a better understanding of what it takes to be successful in the U.S. healthcare market. Mark Lesselroth stated, “I am honored and humbled to be asked by the GHA to talk about the challenges and opportunities associated with the U.S. healthcare market and how to prepare for success accordingly.”

The North America working group meets for the first time on the 15th/16th. April as part of the medical technology conference. All members interested in North America (US & Canada), including non-medical technology companies/organizations, are invited to attend this meeting.

German Health Alliance

The GHA – German Health Alliance consists of more than 100 leading German actors from practically all sectors: business and industry, civil society and NGOs, science and research. The GHA therefore covers a particularly wide range of health expertise with a strong international focus.

Today, there is a need for complete solution packages of uncompromising quality that are flexibly and modularly adapted to the very different, specific needs and challenges. Almost unique to the GHA is its focus on and expertise in systemic strategies to strengthen health infrastructure and improve access to high-quality health services. Innovations and partnerships are key drivers for the activities of the GHA and its members. For this reason, the GHA actors connect practically all sectors with their own network and, far beyond, with governments and international organizations.

This enables the GHA to establish reliable and sustainable long-term partnerships on an equal footing - with a specific focus on global health and excellent, innovative products, solutions and services that are necessary for the widespread strengthening of health systems. All of this makes the GHA a dedicated, extremely suitable access point to internationally sought-after German health expertise.

Mark Lesselroth

Mark is the President and CEO of BioPortUSA, an international business development consultancy specializing in facilitating United States market entry for foreign-based life sciences companies. He has been instrumental in securing and building relationships for international clients such as Siemens, FedEx and GE while bridging Trans Atlantic relations involving foreign trade and investment. Mark is a peer reviewer for the Johns Hopkins Bloomberg School of Public Health and is an active participant in several med-tech clusters both in the USA and Europe.

linkedin.com/in/marklesselroth/

EVENT DETAILS AND REGISTRATION